We have participated in a conference on “Medicine of the Future” at the Roche Institute.

  Through it, a new therapeutic approach for glioblastoma is developed based on using RNAi technology (more specifically siRNA) to reduce the cellular levels of proteins involved in the survival and proliferation of tumor cells.

From October 3 to 5, the XLI National Congress of Pharmacology took place in Palma de Mallorca, where advances in pharmacological and therapeutic research carried out by Spanish Pharmacologists were presented. Within the scientific program

https://www.uclm.es/es/Noticias/Noticias2024/Septiembre/Toledo/gutierrez_tovar_erc